226 related articles for article (PubMed ID: 32949996)
1. Autophagy induction promotes renal cyst growth in polycystic kidney disease.
Lee EJ; Ko JY; Oh S; Jun J; Mun H; Lim CJ; Seo S; Ko HW; Kim H; Oh YK; Ahn C; Kang M; Kim MJ; Yoo KH; Oh GT; Park JH
EBioMedicine; 2020 Oct; 60():102986. PubMed ID: 32949996
[TBL] [Abstract][Full Text] [Related]
2. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and autophagy in polycystic kidney disease (PKD).
Nowak KL; Edelstein CL
Cell Signal; 2020 Apr; 68():109518. PubMed ID: 31881325
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
[TBL] [Abstract][Full Text] [Related]
6. Is autophagy the culprit of cystogenesis in polycystic kidney disease?
Wang S; Dong Z
EBioMedicine; 2020 Nov; 61():103043. PubMed ID: 33038761
[No Abstract] [Full Text] [Related]
7. Netrin-1 Overexpression Induces Polycystic Kidney Disease: A Novel Mechanism Contributing to Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.
Mohamed R; Liu Y; Kistler AD; Harris PC; Thangaraju M
Am J Pathol; 2022 Jun; 192(6):862-875. PubMed ID: 35358475
[TBL] [Abstract][Full Text] [Related]
8. Evidence that TMEM67 causes polycystic kidney disease through activation of JNK/ERK-dependent pathways.
Du E; Li H; Jin S; Hu X; Qiu M; Han R
Cell Biol Int; 2013 Jul; 37(7):694-702. PubMed ID: 23456819
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
[TBL] [Abstract][Full Text] [Related]
10. miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1.
Liu G; Kang X; Guo P; Shang Y; Du R; Wang X; Chen L; Yue R; Kong F
Ren Fail; 2020 Nov; 42(1):333-342. PubMed ID: 32340512
[TBL] [Abstract][Full Text] [Related]
11. CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation.
Zhang Y; Daniel EA; Metcalf J; Dai Y; Reif GA; Wallace DP
J Mol Cell Biol; 2022 Sep; 14(7):. PubMed ID: 36002021
[TBL] [Abstract][Full Text] [Related]
12. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.
Parker MI; Nikonova AS; Sun D; Golemis EA
Cell Signal; 2020 Mar; 67():109497. PubMed ID: 31830556
[TBL] [Abstract][Full Text] [Related]
13. Cyst Reduction by Melatonin in a Novel
Millet-Boureima C; Rozencwaig R; Polyak F; Gamberi C
Molecules; 2020 Nov; 25(22):. PubMed ID: 33238462
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury induces hallmarks of polycystic kidney disease.
Kurbegovic A; Trudel M
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
[TBL] [Abstract][Full Text] [Related]
16. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.
Shillingford JM; Murcia NS; Larson CH; Low SH; Hedgepeth R; Brown N; Flask CA; Novick AC; Goldfarb DA; Kramer-Zucker A; Walz G; Piontek KB; Germino GG; Weimbs T
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5466-71. PubMed ID: 16567633
[TBL] [Abstract][Full Text] [Related]
17. The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
Liu Y; Käch A; Ziegler U; Ong AC; Wallace DP; Arcaro A; Serra AL
PLoS One; 2013; 8(8):e73173. PubMed ID: 24009738
[TBL] [Abstract][Full Text] [Related]
18. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease.
Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R
Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553
[TBL] [Abstract][Full Text] [Related]
20. Effects of PEP-1-FK506BP on cyst formation in polycystic kidney disease.
Jo HS; Eum WS; Park EY; Ko JY; Kim DY; Kim DW; Shin MJ; Son O; Cho SB; Park JH; Lee CH; Yeo EJ; Yeo HJ; Choi YJ; Youn JK; Cho SW; Park J; Park JH; Choi SY
BMB Rep; 2017 Sep; 50(9):460-465. PubMed ID: 28760196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
